moxalactam has been researched along with Infections, Staphylococcal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z; Jing, S; Luan, Y; Mu, D; Wang, D; Wang, L; Wang, T; Wang, Y; Xiang, H; Yang, P | 1 |
| Denis, O; Nonhoff, C; Roisin, S; Struelens, MJ | 1 |
| Aslan, V; Bahar Erdem, G; Çağatay, M; Mert, A; Özel, G; Sencan, I | 1 |
| Casin, I; Felten, A; Grandry, B; Lagrange, PH | 1 |
| Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
| Bansal, MB; Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
| House, B; Leeds, NH; Peyman, GA | 1 |
| Lascola, RJ; Reitberg, DP; Schentag, JJ; Van Tyle, JH; Walczak, P; Wels, PB | 1 |
| Aronoff, SC; Blumer, JL; Husak, M; Kelley, F; Reed, MD; Scoles, PV | 1 |
| Barza, M; Baum, J; Kane, A | 1 |
| Hajsig, D; Skalova, R; Smerdel, S | 1 |
| Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
| Haruta, T; Kobayashi, Y; Okura, K | 1 |
| Maruyama, S; Oka, T; Sanae, N; Takimoto, M; Tsuchida, A; Yoshioka, H | 1 |
| Kumazawa, J; Shinagawa, N | 1 |
| Brister, S; Brown, RA; Chiu, RC; Fradet, G; Mulder, DS; Prentis, J; Richards, GK | 1 |
1 review(s) available for moxalactam and Infections, Staphylococcal
| Article | Year |
|---|---|
[Revaluation of current antimicrobials. Series 16: Latamoxef sodium].
Topics: Adult; Aged; Bacterial Infections; Humans; Methicillin Resistance; Moxalactam; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1994 |
1 trial(s) available for moxalactam and Infections, Staphylococcal
| Article | Year |
|---|---|
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Topics: Abdomen; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Moxalactam; Nutrition Disorders; Prognosis; Random Allocation; Staphylococcal Infections; Staphylococcus; Tobramycin | 1983 |
14 other study(ies) available for moxalactam and Infections, Staphylococcal
| Article | Year |
|---|---|
The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant
Topics: Aminoacyltransferases; Animals; Bacterial Proteins; Biofilms; Caffeic Acids; Cysteine Endopeptidases; Drug Synergism; Female; Humans; Lactates; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Moxalactam; Pneumonia; Staphylococcal Infections | 2020 |
Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin.
Topics: Anti-Bacterial Agents; Automation; Bacterial Proteins; Belgium; Cefoxitin; DNA, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2008 |
[Comparison of oxacillin, cefoxitin, ceftizoxime, and moxalactam disk diffusion methods for detection of methicillin susceptibility in staphylococci].
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftizoxime; Disk Diffusion Antimicrobial Tests; Humans; Latex Fixation Tests; Methicillin; Moxalactam; Oxacillin; Penicillin-Binding Proteins; Predictive Value of Tests; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus | 2011 |
Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.
Topics: Bacterial Proteins; Carrier Proteins; Cefoxitin; Gene Expression Regulation, Bacterial; Hexosyltransferases; Hospitalization; Humans; Lactams; Latex Fixation Tests; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Moxalactam; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcal Infections; Staphylococcus aureus | 2002 |
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1984 |
Newer beta-lactam antibiotics in the treatment of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Rabbits; Staphylococcal Infections | 1984 |
Moxalactam (Moxam) in the treatment of experimental staphylococcal endophthalmitis.
Topics: Animals; Aqueous Humor; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Endophthalmitis; Injections, Intramuscular; Injections, Intravenous; Moxalactam; Rabbits; Retina; Staphylococcal Infections; Vitreous Body | 1982 |
Evaluation of latamoxef as initial therapy of bone and joint infections in childhood.
Topics: Adolescent; Arthritis, Infectious; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Kinetics; Male; Microbial Sensitivity Tests; Moxalactam; Osteomyelitis; Pseudomonas Infections; Staphylococcal Infections | 1984 |
Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis.
Topics: Animals; Cephalosporins; Cephamycins; Conjunctiva; Endophthalmitis; Eye; Injections; Injections, Intramuscular; Moxalactam; Rabbits; Staphylococcal Infections | 1981 |
Interaction of moxalactam and gentamicin: in-vitro study with strains of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Cephalosporins; Cephamycins; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1982 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
Pharmacokinetics in the cerebrospinal fluid after simultaneous administration of latamoxef and ampicillin to rabbits with staphylococcal meningitis.
Topics: Ampicillin; Animals; Drug Therapy, Combination; Injections, Intravenous; Kinetics; Meningitis; Moxalactam; Rabbits; Staphylococcal Infections; Time Factors | 1984 |
[Clinical effect of latamoxef on newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Moxalactam; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis | 1983 |
Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
Topics: Animals; Aorta; Bacterial Infections; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dogs; Escherichia coli Infections; Kinetics; Moxalactam; Muscles; Staphylococcal Infections; Time Factors; Tissue Distribution; Vascular Surgical Procedures | 1986 |